Community-Driven Substance Use Recovery Study
This study is looking at ways to improve access to and engagement in Medication Assisted Treatment (MAT) for people in communities with high rates of opioid overdose. It's testing two approaches: IMANI + church-based telehealth MAT or IMANI + Traditional MAT + Referral and Linkage. IMANI is a faith-based recovery program. You might be able to join if you are 18 or older, have an Alcohol Use Disorder or Opioid Use Disorder, have used alcohol or opioids in the last 28 days, want to reduce your substance use, and live in an area with high overdose rates. The study aims to see how well people attend the program and stick with their treatment over 6 months. The current recruitment status is unclear, but the study plans to enroll 525 participants.
- Study design
- This interventional study plans to enroll 525 participants and compares two different approaches to Medication Assisted Treatment (MAT).
- What's involved
- Participants will engage in the IMANI program and potentially receive MAT, with treatment adherence measured at baseline and 6 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants' treatment adherence will be measured at 6 months, and overall program attendance will be measured for up to 24 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Community Driven Substance Use Recovery for High Opioid Overdose Areas
At a glance
Conditions
Where it's being run
8 sites across 1 statesStudy leadership
- Chyrell Bellamy, Ph.D. · PRINCIPAL_INVESTIGATOR · Yale University
- Ayana Jordan, PhD. · PRINCIPAL_INVESTIGATOR · Yale University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Overall attendance of programUp to 24 weeks
The total number of sessions that participants attend will be used to measure continuation of program.
- Overall treatment adherenceBaseline
The number of participants that adhere to treatments will be measured using self-report at three time points.
- Overall treatment adherence6-month
The number of participants that adhere to treatments will be measured using self-report at three time points.
- Overall treatment adherence12-month
The number of participants that adhere to treatments will be measured using self-report at three time points.